Trial
NCT05941845
Interferon Alfa Therapy Based on Th17 Profile in Membranous Nephropathy
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Centre Hospitalier Universitaire de Nice
Collaborators
—
Condition
Membranous Nephropathy
Intervention
Peginterferon Alfa-2A 180 MCG/ML Injectable Solution
Why stopped
Only screenfail during inclusion period
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-18